| RS397509274 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509275 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397509277 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS397509278 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509279 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS397509283 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397509284 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509286 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS397509287 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509288 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509291 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS397509294 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509295 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397509296 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509297 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509298 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS397509299 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509303 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509304 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509306 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary breast ovarian cancer syndrome |
| RS397509308 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509309 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509310 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509311 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509312 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509314 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509318 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS397509319 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS397509321 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS397509322 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS397509326 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS397509330 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS397509331 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397509332 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509333 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509334 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509335 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509336 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509337 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509338 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397509339 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509340 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397509341 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397509343 |
BRAF
|
Health Risk |
Pathogenic |
Noonan syndrome and Noonan-related syndrome, Noonan syndrome |
| RS397509344 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
LEOPARD syndrome 1, PTPN11-related disorder |
| RS397509345 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS397509360 |
HOGA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria type 3, HOGA1-related disorder |
| RS397509361 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Isolated methylmalonic aciduria cblD type |
| RS397509362 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Isolated methylmalonic aciduria cblD type |
| RS397509363 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS397509364 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS397509365 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS397509366 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS397509367 |
CYP21A2
|
Health Risk |
Pathogenic/Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS397509369 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509370 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509371 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509372 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509373 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509374 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509375 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509376 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS397509377 |
COL3A1
|
Health Risk |
Pathogenic |
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome |
| RS397509379 |
LRIT3
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1F, Congenital stationary night blindness 1F |
| RS397509380 |
LRIT3
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1F, Congenital stationary night blindness 1F |
| RS397509381 |
PDGFRB
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS397509383 |
FKBP10
|
Health Risk |
Pathogenic |
Bruck syndrome 1, Osteogenesis imperfecta type 12 |
| RS397509384 |
PIK3R1
|
Health Risk |
Pathogenic |
Agammaglobulinemia 7, autosomal recessive |
| RS397509385 |
POMK
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS397509386 |
POMK
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS397509387 |
STAMBP
|
Health Risk |
Likely pathogenic |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS397509388 |
STAMBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS397509389 |
STAMBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly-capillary malformation syndrome, Ovarian serous cystadenocarcinoma |
| RS397509390 |
STAMBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS397509391 |
DNMT1
|
Health Risk |
Likely pathogenic |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy |
| RS397509392 |
DNMT1
|
Health Risk |
Pathogenic |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy |
| RS397509393 |
DNMT1
|
Health Risk |
Likely pathogenic |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy |
| RS397509394 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Yunis-Varon syndrome, Yunis-Varon syndrome |
| RS397509395 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Yunis-Varon syndrome, Amyotrophic lateral sclerosis |
| RS397509396 |
B4GAT1
|
Health Risk |
Likely pathogenic |
— |
| RS397509397 |
B4GAT1
|
Health Risk |
Likely pathogenic |
— |
| RS397509398 |
DOCK6
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS397509399 |
DOCK6
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS397509400 |
ERCC4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group Q, Precursor B-cell acute lymphoblastic leukemia |
| RS397509401 |
ERCC4
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group Q, Xeroderma pigmentosum |
| RS397509402 |
ERCC4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group Q, Fanconi anemia complementation group Q |
| RS397509403 |
ERCC4
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, type F/Cockayne syndrome |
| RS397509404 |
ERCC4
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, type F/Cockayne syndrome |
| RS397509405 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS397509406 |
SMARCE1
|
Health Risk |
risk factor |
Familial meningioma, Familial meningioma |
| RS397509407 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS397509408 |
SMARCE1
|
Health Risk |
risk factor |
Familial meningioma, Familial meningioma |
| RS397509410 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 13 |
| RS397509411 |
DYNC1H1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS397509412 |
DYNC1H1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS397509413 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS397509414 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS397509415 |
ASAH1
|
Health Risk |
Pathogenic |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS397509416 |
SMAD2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS397509417 |
TRAPPC11
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Muscular dystrophy |